India · English
'Why only cancer drugs?': SC questions Centre on trade margin cap, seeks wider price regulation
A bench of Justices Vikram Nath and Sandeep Mehta took note of the Centre's decision to impose a 30 per cent cap on trade margins for specified cancer drugs but sought to know why similar scrutiny could not extend to other medicines.
Read the full report at Livemint →
How 2 newsrooms ran it
2 of our sources carried this story over 0.3 hours. Free Press Journal filed first, at 17:38 IST. The headlines below are each outlet's own wording, in the order they published.
| Time IST | Outlet | Their headline |
|---|---|---|
| 17:38 | Free Press Journal | Centre Caps Cancer Drug Trade Margins At 30 Per Cent, Supreme Court Questions High Prices Of Other Medicines |
| 17:55 | Livemint | 'Why only cancer drugs?': SC questions Centre on trade margin cap, seeks wider price regulation |
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.